B Spire

Summary

Country: France

Publications

  1. ncbi Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8)
    Camelia Protopopescu
    Health and Medical Research National Institute INSERM, Research Unit 379, Social Sciences Applied to Medical Innovation, 23, rue Stanislas Torrents, 13006, Marseilles, France
    Qual Life Res 16:577-91. 2007
  2. ncbi Factors associated with efavirenz discontinuation in a large community-based sample of patients
    B Spire
    INSERM U379 ORS PACA, Marseille, France
    AIDS Care 16:558-64. 2004
  3. ncbi Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)
    Bruno Spire
    INSERM U379 ORSPACA, Marseilles, France
    Int J Drug Policy 18:262-70. 2007
  4. ncbi Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment
    Bruno Spire
    Inserm U912, Economic and Social Sciences, Health Systems and Societies, Marseille, France
    Antivir Ther 13:697-703. 2008
  5. ncbi Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART
    S Duran
    INSERM U379, Marseille, Paris, France
    HIV Clin Trials 2:38-45. 2001
  6. doi The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study
    Perrine Roux
    INSERM U912 SE4S, Marseille, France
    Addiction 103:1828-36. 2008
  7. ncbi [Health related quality of life among HIV-HCV co-infected patients]
    M Preau
    INSERM U379 ORS PACA, Marseille
    Rev Epidemiol Sante Publique 54:1S33-1S43. 2006
  8. doi Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116)
    Fabienne Marcellin
    INSERM, Universite Aix Marseille, Marseille, France
    AIDS Care 22:441-51. 2010
  9. doi Psychosocial correlates of inconsistent condom use among HIV-infected patients enrolled in a structured ART interruptions trial in Côte d'Ivoire: results from the TRIVACAN trial (ANRS 1269)
    Camelia Protopopescu
    INSERM, U912, Marseille, France
    Trop Med Int Health 15:706-12. 2010
  10. pmc Susceptibility to transmitting HIV in patients initiating antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial)
    Gilbert Ndziessi
    INSERM, UMR912, SESSTIM, Marseille, France
    PLoS ONE 8:e62611. 2013

Detail Information

Publications82

  1. ncbi Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8)
    Camelia Protopopescu
    Health and Medical Research National Institute INSERM, Research Unit 379, Social Sciences Applied to Medical Innovation, 23, rue Stanislas Torrents, 13006, Marseilles, France
    Qual Life Res 16:577-91. 2007
    ..However, any analysis of such extensive longitudinal data necessitates a suitable handling of dropout which may correlate with patients' health status...
  2. ncbi Factors associated with efavirenz discontinuation in a large community-based sample of patients
    B Spire
    INSERM U379 ORS PACA, Marseille, France
    AIDS Care 16:558-64. 2004
    ..7[1-2.5]) and multiple episodes of depression (2.6[1.5-4.5]). Clinicians should keep in mind the neuropsychiatric risks of EFV during the first year, especially among patients with a history of multiple depressive episodes...
  3. ncbi Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)
    Bruno Spire
    INSERM U379 ORSPACA, Marseilles, France
    Int J Drug Policy 18:262-70. 2007
    ..The review concludes by suggesting areas of future research targeted at improving the understanding of both the role of perceived toxicity and patient-provider relationship for patients on ART and OST...
  4. ncbi Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment
    Bruno Spire
    Inserm U912, Economic and Social Sciences, Health Systems and Societies, Marseille, France
    Antivir Ther 13:697-703. 2008
    ..A cross-sectional study was performed 24 months after ART initiation for patients treated in Cambodia in order to estimate the prevalence and identify determinants of non-adherence...
  5. ncbi Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART
    S Duran
    INSERM U379, Marseille, Paris, France
    HIV Clin Trials 2:38-45. 2001
    ..CONCLUSION: Patients reporting a high number of symptoms soon after HAART initiation are at higher risk of future nonadherence and could be targeted for interventions to achieve good levels of adherence and to improve treatment outcome...
  6. doi The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study
    Perrine Roux
    INSERM U912 SE4S, Marseille, France
    Addiction 103:1828-36. 2008
    ..This study was conducted in order to evaluate whether receiving take-home methadone and buprenorphine may ensure better adherence to HAART in individuals infected with human immunodeficiency virus (HIV) through injection drug use (IDU)...
  7. ncbi [Health related quality of life among HIV-HCV co-infected patients]
    M Preau
    INSERM U379 ORS PACA, Marseille
    Rev Epidemiol Sante Publique 54:1S33-1S43. 2006
    ....
  8. doi Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116)
    Fabienne Marcellin
    INSERM, Universite Aix Marseille, Marseille, France
    AIDS Care 22:441-51. 2010
    ..7 [1.2-2.4]). As a conclusion, the desire to have a child is frequent among ART-treated WLHA in Cameroon. HIV care and family planning programs should be integrated more thoroughly in order to support WLHA's reproductive choices...
  9. doi Psychosocial correlates of inconsistent condom use among HIV-infected patients enrolled in a structured ART interruptions trial in Côte d'Ivoire: results from the TRIVACAN trial (ANRS 1269)
    Camelia Protopopescu
    INSERM, U912, Marseille, France
    Trop Med Int Health 15:706-12. 2010
    ..To investigate the relationship between unsafe sexual behaviours and poor self-perceived health among people living with HIV and AIDS (PLWHA) in western Africa...
  10. pmc Susceptibility to transmitting HIV in patients initiating antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial)
    Gilbert Ndziessi
    INSERM, UMR912, SESSTIM, Marseille, France
    PLoS ONE 8:e62611. 2013
    ..Using cohort data nested in a randomized trial conducted in Cameroon, this study aimed to investigate time trends and predictors of the susceptibility to transmitting HIV during the first 24 months of treatment...
  11. ncbi Sexual difficulties in people living with HIV in France--results from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA)
    Anne Deborah Bouhnik
    Health and Medical Research National Institute INSERM, Research Unit 379, Social Sciences Applied to Medical Innovation, Institut Paoli Calmettes, Marseilles, France
    AIDS Behav 12:670-6. 2008
    ..HIV and HIV-treatment experience are associated with sexual difficulties. Psychological support focused on HIV-experience should be tested as a possible tool for improving sexual quality of life...
  12. ncbi Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003)
    P Peretti-Watel
    Regional Centre for Disease Control of South Eastern France, Marseilles, France
    AIDS Care 18:254-61. 2006
    ....
  13. ncbi Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow up
    Emmanuelle Vincent
    INSERM U379 ORS PACA, Marseilles, France
    AIDS 18:1321-5. 2004
    ..DESIGNAND PARTICIPANTS: HAART-treated patients who reported having occasional partners during the follow-up period after HAART initiation were selected among patients of the MANIF 2000 cohort of HIV-infected drug users...
  14. ncbi Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach
    Bruno Spire
    INSERM U 379, Torrents, Marseille, France
    Soc Sci Med 54:1481-96. 2002
    ..It suggests that a dynamic approach to adherence, continuously monitoring the impact of experience with HAART on patients' daily lives, is needed for improving management of HIV/AIDS care...
  15. ncbi Nonadherence among HIV-infected injecting drug users: the impact of social instability
    Anne Deborah Bouhnik
    Regional Center for Disease Control of Southeastern France ORS PACA, Marseilles, France
    J Acquir Immune Defic Syndr 31:S149-53. 2002
    ..For ex-IDUs, it is very important that the management of social difficulties be taken into account to increase adherence to HAART...
  16. doi Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods
    Perrine Roux
    INSERM, U912, SE4S, Marseille, Bouches du rhone, France
    J Acquir Immune Defic Syndr 57:S40-3. 2011
    ..Antiretroviral treatment (ART) scale-up in sub-Saharan Africa has made it possible to investigate the maintenance of adherence to HIV medications. We describe here adherence to ART and identify its correlates in the Cameroonian context...
  17. ncbi Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy
    S Duran
    INSERM U379, Marseille, France
    AIDS 15:2441-4. 2001
    ..After multiple adjustment for other related factors, such as younger age, alcohol consumption and poor housing conditions, the number of self-reported lipodystrophy symptoms was independently associated with adherence failure...
  18. ncbi Health-related quality of life after 1 year of highly active antiretroviral therapy
    Patrizia Carrieri
    INSERM U379 ORS, Marseille, France
    J Acquir Immune Defic Syndr 32:38-47. 2003
    ..We investigated the impact of the first year of highly active antiretroviral therapy (HAART) on health-related quality of life (HRQL)...
  19. ncbi Awareness of non-occupational HIV postexposure prophylaxis among French people living with HIV: the need for better targeting
    Dominique Rey
    South Eastern Health Regional Observatory ORS PACA, Marseille, France
    AIDS 21:S71-6. 2007
    ..This study analysed factors associated with PEP awareness in a population of individuals living with HIV/AIDS (PLHAs)...
  20. ncbi Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial
    Bruno Spire
    NSERM U912 Economic Et Social Sciences, Health Systems Et Societies, Marseilles, France
    Antivir Ther 13:591-9. 2008
    ..We present data from the MONARK trial concerning QOL and patient-reported symptoms...
  21. ncbi Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy
    Anne Deborah Bouhnik
    INSERMU379 ORS PACA, Marseilles, France
    Antivir Ther 10:53-61. 2005
    ..To disentangle the impact of adherence from that of injecting drug status and depressive syndrome on HIV clinical progression in a cohort of highly active antiretroviral therapy (HAART)-treated HIV patients infected through drug use...
  22. doi Simplification and first validation of a short battery of patient questionnaires for clinical management of HIV-infected patients: The HIV-SQUAD (Symptom Quality of life Adherence) Questionnaire
    B Spire
    INSERM U379, Marseille, France
    HIV Clin Trials 10:215-32. 2009
    ..Questionnaires assessing patient-reported outcomes in HIV are either too long or not HIV-specific. Our aim was to develop and validate a simplified HIV patient questionnaire...
  23. doi Higher risk of unsafe sex and impaired quality of life among patients not receiving antiretroviral therapy in Cameroon: results from the EVAL survey (ANRS 12-116)
    Fabienne Marcellin
    INSERM, U912 SE4S, Marseille, France
    AIDS 24:S17-25. 2010
    ..Current clinical research suggests these criteria may be too stringent. This study aimed at evaluating the effect of not receiving ART on patients' psychosocial outcomes...
  24. ncbi The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination
    Ségolène Duran
    INSERM U379, Marseille, France
    AIDS 17:1096-9. 2003
    ..The relationship between non-adherence and a detectable HIV viral load was enhanced when adherent patients with PPIC below LOQ were considered to be non-adherent. PPIC combined with self-report may more reliably detect non-adherence...
  25. ncbi Drug injection cessation among HIV-infected injecting drug users
    Anne Deborah Bouhnik
    Observatoire Régional de la Santé, Marseilles, France
    Addict Behav 29:1189-97. 2004
    ....
  26. ncbi Concealment of HIV and unsafe sex with steady partner is extremely infrequent
    Bruno Spire
    INSERM U379 ORS PACA, Marseille, France
    AIDS 19:1431-3. 2005
  27. ncbi Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study
    Marie Preau
    1 INSERM Research Unit 379 Epidemiology and Social Sciences Applied to Medical Innovation, Marseille, France
    AIDS 21:S19-27. 2007
    ..Since the advent of HAART, the assessment of health-related quality of life (HRQL) has become a major concern in the therapeutic follow-up of people living with HIV...
  28. ncbi Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients
    P Peretti-Watel
    Regional Centre for Disease Control of South Eastern France, Marseille, France
    Soc Sci Med 62:2420-33. 2006
    ..Theoretical models used for designing behavioural interventions should take into account this diversity...
  29. ncbi Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116)
    Fabienne Marcellin
    INSERM U912 ORS PACA, 23 rue Stanislas Torrents, 13006 Marseille, France
    Trop Med Int Health 13:1470-8. 2008
    ..To identify correlates of self-reported antiretroviral therapies (ART) interruptions among people living with HIV and AIDS (PLWHA) in Cameroon...
  30. ncbi Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment
    M Preau
    INSERM U379 ORS, Marseille and University Aix Marseille, Aix en Provence, France
    AIDS Care 16:649-61. 2004
    ..These results underline the need to improve patient-provider relationships to optimize long-term HRQL. Socio-behavioural interventions should focus on this goal...
  31. doi Delayed first consultation after diagnosis of HIV infection in Cameroon
    Fabienne Marcellin
    INSERM U912 SE4S, ORS PACA, Observatoire Régional de la Santé Provence Alpes Côte d Azur, 23 rue Stanislas Torrents, 13006 Marseille, France
    AIDS 23:1015-9. 2009
    ..To study the impact of both decentralization of HIV care and individual factors on delayed first consultation (> or =6 months) after HIV diagnosis in Cameroon, in the context of the national antiretroviral treatment scale-up program...
  32. doi Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data
    Camelia Protopopescu
    INSERM, U912 SE4S, 13006 Marseille, France
    J Antimicrob Chemother 64:599-606. 2009
    ..The aim of this study was to identify factors associated with non-adherence over a 10 year follow-up of the APROCO-COPILOTE cohort during the maintenance phase of highly active antiretroviral therapy (HAART)...
  33. ncbi Time perspective and quality of life among HIV-infected patients in the context of HAART
    M Preau
    Social Health Psychology Department, Aix Marseille I, Aix en Provence, France
    AIDS Care 19:449-58. 2007
    ..Specific dimensions of QOL are influenced by specific orientations of TP, which provides information on self-perception and subjective evaluation of QOL. The TP construct provides keys to managing HIV infection in order to improve QOL...
  34. doi Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management
    Perrine Roux
    INSERM, U912 Economic and Social Sciences, Health Systems and Societies, Marseille, France
    Drug Alcohol Depend 97:105-13. 2008
    ..The aim of this study was to identify which factors are predictive of buprenorphine injection in patients receiving office-based buprenorphine...
  35. doi Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138)
    Thomas Boulet
    INSERM SC10, Villejuif, France
    HIV Clin Trials 11:283-93. 2010
    ..We investigated whether a switch from enfuvirtide to raltegravir, an orally available HIV-integrase inhibitor, may improve health-related quality of life (HRQoL)...
  36. ncbi Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients
    Marie Preau
    Health and Medical Research National Institute INSERM, Research Unit 379, Marseille, France
    J Clin Gastroenterol 42:92-6. 2008
    ..To study the specific impact of treatments for chronic hepatitis C virus (HCV) infection on anger expression and control in adult patients coinfected with HIV and HCV receiving antiretroviral therapy...
  37. doi Buprenorphine sniffing as a response to inadequate care in substituted patients: results from the Subazur survey in south-eastern France
    Perrine Roux
    INSERM, U912 SE4S, Marseille, France
    Addict Behav 33:1625-9. 2008
    ..The Subazur survey gave us the opportunity to identify factors associated with buprenorphine sniffing in patients receiving buprenorphine in primary care...
  38. ncbi How do HIV-infected smokers react to cigarette price increases? Evidence from the APROCO-COPILOTE-ANRS CO8 Cohort
    Patrick Peretti-Watel
    INSERM, U912 SE4S, Marseille, France
    Curr HIV Res 7:462-7. 2009
    ..Raising cigarette prices is usually considered as one of the most effective ways to reduce smoking, but its effectiveness has never been studied among HIV-infected smokers...
  39. pmc HIV prevention: What have we learned from community experiences in concentrated epidemics?
    Bruno Spire
    INSERM, U912 SE4S, Marseille, France
    J Int AIDS Soc 11:5. 2008
    ..Note: this paper corresponds to the plenary talk of Bruno Spire at the XVIIth World AIDS Conference, August 8th, Mexico city: http://www.kaisernetwork.org/health_cast/player.cfm?id=4383...
  40. doi Disclosure and religion among people living with HIV/AIDS in France
    Marie Preau
    LabECD, Psychology Department, Nantes University, Nantes, France
    AIDS Care 20:521-6. 2008
    ..In conclusion, individuals who place importance on religion appear to have difficulties in disclosing their HIV-positive status due to the associated stigma and fear of discrimination...
  41. ncbi Smoking motivations and quitting motivations among HIV-infected smokers
    Patrick Peretti-Watel
    Inserm UMR912, SE4S, Marseille, France
    Antivir Ther 14:781-7. 2009
    ..The aim of this study was to examine smoking motivation and motivation to quit, and determinants of these motivations among HIV-infected cigarette smokers...
  42. doi HIV disclosure and unsafe sex among HIV-infected women in Cameroon: results from the ANRS-EVAL study
    Sandrine Loubiere
    INSERM, U912 SE4S, Marseille, France
    Soc Sci Med 69:885-91. 2009
    ..On the contrary, beliefs overestimating the effectiveness of antiretroviral therapies were quite widespread among respondents and predictive of both concealment of HIV status and unsafe sex...
  43. pmc Financial barriers to HIV treatment in Yaoundé, Cameroon: first results of a national cross-sectional survey
    Sylvie Boyer
    INSERM IRD U912 SE4S, Universite Aix Marseille, 23 rue Stanislas Torrents, Marseille, France
    Bull World Health Organ 87:279-87. 2009
    ..To assess the extent to which user fees for antiretroviral therapy (ART) represent a financial barrier to access to ART among HIV-positive patients in Yaoundé, Cameroon...
  44. doi Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers
    Sandrine Loubiere
    INSERM, U912 SE4S, Marseille, France
    Health Policy 92:165-73. 2009
    ..The national antiretroviral treatment (ART) program in Cameroon has reached one of the highest rate of coverage in Western and Central Africa (58% of the estimated eligible HIV-infected population in June 2008)...
  45. ncbi Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment
    Perrine Roux
    Institut National de la Sante et de la Recherche Medicale, U912 SE4S, Marseille, France
    Clin Infect Dis 49:1433-40. 2009
    ..We selected a total of 113 patients, accounting for a total of 562 visits for all the analyses...
  46. ncbi The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice
    Virginie Villes
    INSERM U379, Marseilles, France
    Antivir Ther 12:1067-74. 2007
    ..This is especially true for those studies that also consider the possible confounding influence of patient's adherence to treatment...
  47. ncbi Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research
    Fabienne Marcellin
    Health and Medical Research National Institute INSERM Research Unit 379, Epidemiology and Social Sciences Applied to Medical Innovation, Marseilles, France
    HIV Clin Trials 8:320-7. 2007
    ..To analyze the impact of self-reported fatigue and depressive symptoms on the quality of life (QOL) of patients co-infected with HIV and hepatitis C virus (HCV) not receiving anti-HCV therapy...
  48. ncbi Health-related quality of life and health locus of control beliefs among HIV-infected treated patients
    Marie Preau
    INSERM U379 ORS, Marseille, France
    J Psychosom Res 59:407-13. 2005
    ....
  49. ncbi Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003)
    Patrick Peretti-Watel
    Regional Centre for Disease Control of South Eastern France, Marseilles, France
    Drug Alcohol Depend 82:S71-9. 2006
    ....
  50. ncbi Health related quality of life among both current and former injection drug users who are HIV-infected
    Marie Preau
    National Health Institute INSERM U379 Southeastern Health Regional Observatory ORS PACA, 23 rue Stanislas Torrents, 13006 Marseilles, France
    Drug Alcohol Depend 86:175-82. 2007
    ....
  51. ncbi Unprotected sex in regular partnerships among homosexual men living with HIV: a comparison between sero-nonconcordant and seroconcordant couples (ANRS-EN12-VESPA Study)
    Anne Deborah Bouhnik
    Health and Medical Research National Institute INSERM, Research Unit 379, Social Sciences Applied to Medical Innovation, Institut Paoli Calmettes, Marseille, France
    AIDS 21:S43-8. 2007
    ..We investigated factors associated with unprotected sex in regular partnerships among homosexual men living with HIV...
  52. ncbi Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study
    Rosemary Dray-Spira
    INSERM, U687, Saint Maurice, and Université Paris XI, IFR69, Villejuif, and Hôpital Européen Georges Pompidou, Service d immunologie clinique, Paris, France
    AIDS 21:S5-12. 2007
    ..Benefits from HAART may be heterogeneous across people living with HIV. We measured the differences in the rate of HAART failure across the various subgroups represented at the level of a country...
  53. ncbi Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase
    Maria Patrizia Carrieri
    INSERM U379, Marseille, France
    J Acquir Immune Defic Syndr 41:477-85. 2006
    ..Reasons for nonadherence are multifactorial. Psychosocial interventions and the selection of the best-tolerated regimens are needed to improve long-term adherence of HIV-infected patients to their lifelong treatment...
  54. ncbi Drug resistance and adherence to HIV/AIDS antiretroviral treatment: against a double standard between the north and the south
    Jean Paul Moatti
    University of the Mediterranean, INSERM Research Unit 379, Marseilles, France
    AIDS 18:S55-61. 2004
    ....
  55. pmc Factors associated with liver biopsy performance in HCV-HIV coinfected injecting drug users with HCV viremia: results from a five-year longitudinal assessment
    Dominique Rey
    Regional Center for Disease Control ORS PACA of Southeastern France, 23 rue Stanislas Torrents, 13006 Marseille, France
    J Urban Health 81:48-57. 2004
    ..These results suggest that specific efforts should be devoted to HIV-HCV coinfected drug users to assist with stabilizing these patients to optimize their access to HCV care whenever possible...
  56. ncbi Unsafe sex in regular partnerships among heterosexual persons living with HIV: evidence from a large representative sample of individuals attending outpatients services in France (ANRS-EN12-VESPA Study)
    Anne Deborah Bouhnik
    Health and Medical Research National Institute INSERM, Research Unit 379, Social Sciences Applied to Medical Innovation, Institut Paoli Calmettes, Marseille, France
    AIDS 21:S57-62. 2007
    ..Risky sexual behaviour remains frequent among people living with HIV. We analysed factors associated with unsafe sex within serodiscordant couples among heterosexual individuals living with HIV in France...
  57. ncbi Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study
    Maria Patrizia Carrieri
    INSERM U379, Marseille, France
    Antivir Ther 8:585-94. 2003
    ....
  58. ncbi Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects
    Fabienne Marcellin
    Research Unit 379, National Institute of Health and Medical Research INSERM, Institut Paoli Calmettes, 23 rue Stanislas Torrents, 13006 Marseilles, France
    J Pain Symptom Manage 34:413-21. 2007
    ..Effective follow-up of HCV-treated HIV-coinfected patients should, therefore, include close consideration and management of patients' subjective experience with treatments to reduce the burden of HCV-associated fatigue...
  59. pmc Discrimination against HIV-infected people and the spread of HIV: some evidence from France
    Patrick Peretti-Watel
    Institut National de la Sante et de la Recherche Medicale INSERM, Unit 379, Social Sciences Applied to Medical Innovation, Marseille, France
    PLoS ONE 2:e411. 2007
    ..To contribute to this debate, we analysed the relationship between perceived discrimination and unsafe sex in a large sample of French PLWHAs...
  60. ncbi Unsafe sex with casual partners and quality of life among HIV-infected gay men: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA)
    Anne Deborah Bouhnik
    Regional Centre for Disease Control of South Eastern France, ORS PACA, Marseille, France
    J Acquir Immune Defic Syndr 42:597-603. 2006
    ..It was proposed to study the influences of lifestyle characteristics and health-related quality of life (HRQL) on unsafe sex with casual partners in a representative sample of HIV-infected gay men...
  61. pmc No variability across centers in adherence and response to HAART in French hospitals: results from the ANRS-EN12-VESPA study
    Remi Sitta
    INSERM U687 IFR69, Villejuif, France
    J Acquir Immune Defic Syndr 52:643-7. 2009
    ....
  62. ncbi [Seropositive people infected through intravenous drug use: a persistent vulnerability]
    Patrick Peretti-Watel
    Observatoire régional de la santé de Provence Alpes Côte d Azur, INSERM U379, Marseille
    Rev Prat 55:2093-100. 2005
    ..Among patients infected through IDU, material vulnerability and experience of discrimination from health professionals were significantly associated with poor adherence to highly active antiretroviral therapies...
  63. ncbi [Economic and socio-behavioural issues related to highly active antiretroviral therapies for HIV infection: the contribution of social science research]
    Jean Paul Moatti
    INSERM U 379, Sciences sociales appliquées à l innovation médicale, Institut Paoli Calmettes, 232, boulevard de Sainte Marguerite, 13273 Marseille Cedex 09, France
    Med Sci (Paris) 19:878-84. 2003
    ....
  64. doi Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician
    P Roux
    INSERM, U912 SE4S, Marseille, France
    Drug Alcohol Depend 116:228-32. 2011
    ....
  65. ncbi Oral contraception and unprotected sex with occasional partners of women HIV-infected through injection drug use
    M P Carrieri
    INSERM Research Unit 379, Marseille, France
    AIDS Care 18:795-800. 2006
    ..Risk reduction counselling and interventions are needed to promote either the use of dual contraception or, alternatively, that of female condom...
  66. ncbi Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study
    Christian Pradier
    INSERM U379, Marseilles, France
    HIV Clin Trials 4:121-31. 2003
    ..The objective was to evaluate the impact of an intervention for improving adherence to antiretroviral therapies (HAART) in HIV-infected patients...
  67. ncbi A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells
    F Rey
    INSERM U372, Marseille, France
    J Gen Virol 79:1083-7. 1998
    ..Our data indicate that Vpr is involved in the virus life-cycle during infection of dividing PBMC, presumably as it is during infection of MDMs...
  68. ncbi The HIV-1 Vpr co-activator induces a conformational change in TFIIB
    I Agostini
    INSERM U372, Marseille, France
    FEBS Lett 450:235-9. 1999
    ..Our data show a correlation between the ability of Vpr-mutated proteins to stimulate transcription and their ability to induce a conformational change in TFIIB, indicating a functional relevance of the Vpr-TFIIB interaction...
  69. ncbi 'Forced treatment interruptions' and risk of HIV resistance in countries adopting law enforcement against marginalized populations
    Maria Patrizia Carrieri
    AIDS 21:1062-3. 2007
  70. pmc R57K polymorphism in the human immunodeficiency virus type 1 protease as predictor of early virological failure in a cohort of antiretroviral-naive patients treated mostly with a nelfinavir-containing regimen
    Bernard Masquelier
    Laboratoire de Virologie, Hopital Pellegrin, Bordeaux, France
    Antimicrob Agents Chemother 47:3623-6. 2003
    ....
  71. ncbi Indinavir plasma concentration and adherence score are codeterminant of early virologic response in HIV-infected patients of the APROCO cohort
    Xavier Duval
    Laboratoire de Recherche en Pathologie Infectieuse, Faculte Xavier Bichat, Paris, France
    Ther Drug Monit 27:63-70. 2005
    ..These data suggest that any strategy of therapeutic drug monitoring must imply first a combined evaluation of plasma concentrations and adherence level and second an intervention target based on the results of both assessments...
  72. ncbi Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment
    Laurent Ferradini
    Epicentre, Paris, France
    Lancet 367:1335-42. 2006
    ..We aimed to assess the effectiveness of such a programme held by Médecins Sans Frontières (MSF) in the Chiradzulu district, Malawi...
  73. ncbi Prevalence and predictors of deterioration of a trustful patient-provider relationship among HIV-infected persons treated with antiretroviral therapy
    Marie Preau
    Laboratory of Psychology, Laboratoire Education Cognition et Développement, Nantes University, Nantes, France
    J Acquir Immune Defic Syndr 47:467-71. 2008
    ..We studied the evolution of the patient-provider relationship (PPR) in HIV-infected patients who reported trustful relationships at highly active antiretroviral therapy (HAART) treatment initiation...
  74. pmc Factors correlated with disclosure of HIV infection in the French Antilles and French Guiana: results from the ANRS-EN13-VESPA-DFA Study
    Kim Bouillon
    INSERM Research Unit 687 IFR69 Public Health and Epidemiology of the Social and Occupational Determinants of Health, Saint Maurice, France
    AIDS 21:S89-94. 2007
    ..To determine the rate, patterns and predictors of HIV disclosure in the French Antilles and French Guiana...
  75. pmc Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study
    Xavier Duval
    INSERM, Clinical Investigation Center 007, Inserm 738, Bichat, Paris, France
    Antivir Ther 13:389-97. 2008
    ..To assess the prevalence of and factors associated with tobacco smoking and dependence in HIV patients...
  76. ncbi [Mental health of HIV-positive women in France in the era of antiretroviral therapies: what differences between men and women? What is at stake?]
    Marie Preau
    LabECD, Universite de Nantes, Nantes
    Med Sci (Paris) 24:151-60. 2008
  77. doi Harm reduction and control of HIV in IDUs in France
    M Patrizia Carrieri
    Lancet 372:448. 2008
  78. ncbi Do migrants overreport adherence to highly active antiretroviral therapy?: results from the French VESPA (ANRS-EN12) National Survey
    Fabienne Marcellin
    J Acquir Immune Defic Syndr 42:646-7. 2006
  79. ncbi Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8)
    Maria Patrizia Carrieri
    INSERM U379, 23 rue Stanislas Torrents, 13006 Marseilles, France
    Int J Drug Policy 18:288-95. 2007
    ....
  80. ncbi [Couple life, gender and HIV disease]
    France Lert
    Unité Inserm 687, Saint Maurice
    Med Sci (Paris) 24:33-40. 2008
  81. doi Editorial: contexts and complexity - special considerations in HIV and social science
    Lorraine Sherr
    AIDS Care 20:507-8. 2008
  82. doi HIV/AIDS: a long-term research agenda for social sciences
    Jean Paul Moatti
    AIDS Care 20:407-12. 2008